- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
April 19, 2021Robins Kaplan Recommits to ABA Pledge on Well-being in the Legal Profession
-
April 16, 2021Ronald Schutz Named 2021 Lawdragon Legend
-
April 14, 2021Robins Kaplan Secures Asylum, Relative Petition for Somali Journalist
-
April 13, 20, and 27, 2021Conversations on Cross-Border IP Protection and Enforcement
-
April 28, 2021Creating the Audit Clause for Today’s Compliance Review
-
April 29, 2021International Intellectual Property: Challenges of Cross-Border Litigation
-
First QuarterANDA Approvals
-
First QuarterANDA Litigation Settlements
-
First QuarterGeneric Launches
-
April 19, 2021Financial Daily Dose 4.19.2021 | Top Story: Bitcoin Plummets In Correction Following Coinbase’s Public Debut
-
April 16, 2021Financial Daily Dose 4.16.2021 | Top Story: Lower Jobless Claims and Big U.S. Retail Sales Power Dow Above 34,000
-
April 15, 2021Financial Daily Dose 4.15.2021 | Top Story: Big Banks Deliver Huge Q1 Profits, Economic Optimism Despite Ongoing Challenges
Consumer Alert:
Imprelis® MDL Created and Information on Imprelis® Claims Program
October 28, 2011
The DuPont chemical company's Imprelis® herbicide has been linked to the significant damage and death of desirable vegetation including trees, shrubs, and ornamental plants. On August 10, the Environmental Protection Agency (EPA) ordered DuPont to halt the sale, use, and distribution of the chemical. [1]
On October 20, 2011, the U.S. Judicial Panel on Multidistrict Litigation (MDL) decided to consolidate Imprelis® cases for pretrial proceedings in the Eastern District of Pennsylvania. The Panel chose the Eastern District of Pennsylvania in part because the EPA office responsible for investigating and handling Imprelis® is located in Philadelphia. Robins, Kaplan, Miller & Ciresi L.L.P. is handling Imprelis® claims and plans on being actively involved in these MDL proceedings, following the Minnesota class action lawsuit we filed in August 2011 against the DuPont chemical company over Imprelis®.
DuPont has announced a "claims resolution process" for Imprelis® damage to evergreen trees. At this point, it is not certain that the process will provide full compensation to Imprelis® victims. DuPont has provided few details about the program. [2] DuPont says it will compensate lawn care professionals for the removal and replacement of trees destroyed by Imprelis®, but makes only vague statements that it will provide property owners a "direct payment based on a fixed percentage of the total validated claim." DuPont does not define what constitutes a "validated claim," nor does it specify what "fixed percentage" it may pay. Regarding large trees, DuPont states that when it "is not feasible" to replace a tree with one of a similar size, "DuPont will provide a recommended solution to address the situation." DuPont provides no details as to what that "solution" might be. Additionally, to receive any benefits under the program, homeowners "will be required to sign a release that waives [their] right to file or participate in any lawsuit related to Imprelis®."
Our team of experienced mass tort attorneys, legal nurse consultants and other professionals have earned a national reputation for tirelessly fighting for justice for our clients. We welcome calls from referring attorneys or potential clients. Contact us at 1-800-553-9910 or at 1-612-349-8500 or by clicking here.
Other Investigations and Litigation:
- DePuy ASR Hip Implants
- DePuy Pinnacle Hip Implants
- Fosamax
- Zimmer Durom Cup Hip Implant
- Zimmer NexGen Knee Replacements
© Copyright 2011. All rights reserved.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Gary L. Wilson
Partner
Kate E. Jaycox
Partner
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.